BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

261 hedge funds and large institutions have $5.69B invested in Blueprint Medicines in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 102 increasing their positions, 93 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
261
Holders Change
-15
Holders Change %
-5.43%
% of All Funds
4.6%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
35
Increased
102
Reduced
93
Closed
46
Calls
$8.55M
Puts
$17.3M
Net Calls
-$8.74M
Net Calls Change
+$24.4M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$67.6M
2
Jennison Associates
2
Jennison Associates
New York
$40.1M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$394M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$536M
5
APM
5
Avidity Partners Management
Texas
$53.1M

Top Sellers

1
HA
1
HHLR Advisors
Cayman Islands
$73.8M
2
PAMU
2
Pictet Asset Management (UK)
United Kingdom
$68M
3
EVM
3
Eaton Vance Management
Massachusetts
$27.6M
4
Morgan Stanley
4
Morgan Stanley
New York
$6.03M
5
SAM
5
Sectoral Asset Management
Quebec, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ASN
301
Advisory Services Network
Georgia
– -$3K -31 Closed
CFGS
302
Concourse Financial Group Securities
Alabama
– -$3K -25 Closed
ICP
303
Interchange Capital Partners
Pennsylvania
– -$2K -23 Closed
Kayne Anderson Rudnick Investment Management
304
Kayne Anderson Rudnick Investment Management
California
– -$1K -7 Closed
9 10 11 12
13